OTCMKTS:BNOEF Bionomics (BNOEF) Stock Price, News & Analysis → My 3 Top Cryptocurrencies (From Manward Press) (Ad) Free BNOEF Stock Alerts $0.0034 0.00 (-43.33%) (As of 09/19/2023) Add Compare Share Share Today's Range$0.0034▼$0.003450-Day Range N/A52-Week Range$0.00▼$0.06Volume22,900 shsAverage Volume140,299 shsMarket Capitalization$4.45 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisHeadlinesStock AnalysisHeadlines Get Bionomics alerts: Email Address Ad The Freeport SocietyThe last Republican president?History shows Donald Trump is poised to go down as the last Republican President for a generation or more. How is this possible, with Biden so unpopular, and Trump running at least neck-in-neck with him in polls?This presentation explains exactly why. About Bionomics Stock (OTCMKTS:BNOEF)Bionomics Limited, a clinical stage biopharmaceutical company, discovers and develops novel drug candidates for the treatment of central nervous system disorders and cancers. The company's lead drug candidate includes BNC210, a negative allosteric modulator of the a7 nicotinic acetylcholine receptor, which is in phase 2 clinical trial for the treatment of social anxiety disorder and phase 2b to treat post-traumatic stress disorder. It also develops BNC101, a monoclonal antibody that has completed phase 1 clinical trial that targets cancer stem cells; and BNC105, which is in phase 2 clinical trial for the treatment of refractory colorectal cancer and phase 1 clinical trial for the treatment of patients with relapsed/refractory chronic lymphocytic leukemia. Bionomics Limited was incorporated in 1996 and is based in Eastwood, Australia.Read More BNOEF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart BNOEF Stock News HeadlinesMay 9, 2024 | bbc.comKendrick Lamar’s beef with Drake and J Cole explainedApril 17, 2024 | bbc.co.ukChilli beef udon noodlesMarch 21, 2024 | msn.comBionomics to advance non-SSRI PTSD candidate to Phase IIIJanuary 5, 2024 | tmcnet.comBionomics to Present at Biotech Showcase™ 2024December 30, 2023 | bbc.co.ukPeter Bone MP loses seat as recall petition triggers by-electionDecember 6, 2023 | msn.comBionomics presents data on reliability of the Subjective Units of Distress ScaleOctober 16, 2023 | markets.businessinsider.comBionomics Secures Buy Rating Amidst Promising BNC210 Developments and Potential Market Entry AdvantageSeptember 29, 2023 | msn.comBionomics stock rockets 415% on positive study for PSTD drugSeptember 28, 2023 | proactiveinvestors.comBionomics shares soar almost 400% after positive phase IIb results from PTSD treatmentSeptember 28, 2023 | marketwatch.comBionomics Shares Take Flight on Positive PTSD Study ResultsSeptember 28, 2023 | marketwatch.comBionomics Shares Rally Premarket on Phase 2B PTSD Study SuccessSeptember 28, 2023 | markets.businessinsider.comBionomics: Phase 2b ATTUNE Trial With BNC210 Meets Primary Endpoint - Quick FactsSeptember 28, 2023 | msn.comBionomics announces positive results in trial of treatment for PTSDSeptember 26, 2023 | ftw.usatoday.comJay Norvell's beef with Deion Sanders and Colorado is so good for college footballSeptember 14, 2023 | finance.yahoo.comBionomics Announces Update on the α7 Nicotinic Acetylcholine Receptor (nAChR) Positive Allosteric Modulator (PAM) Collaboration with MSDJuly 9, 2023 | usatoday.comMike Trout suffers broken hamate bone, likely out six to eight weeksApril 27, 2023 | finance.yahoo.comBionomics Announces the Completion of Enrollment in Phase 2b ATTUNE Clinical Trial of BNC210 in Patients with Post-Traumatic Stress Disorder (PTSD)March 10, 2023 | markets.businessinsider.comPositive Report for Bionomics (BNOX) from Evercore ISIMarch 8, 2023 | finance.yahoo.comBionomics Reports Promising Full Results Analysis from PREVAIL Phase 2 Study of BNC210 Social Anxiety Disorder (SAD)March 3, 2023 | msn.comBears are Losing Control Over Bionomics Limited Unsponsored ADR (BNOX), Here's Why It's a 'Buy' NowFebruary 10, 2023 | finance.yahoo.comBionomics Limited (BNOEF) Stock Historical Prices & Data - Yahoo FinanceDecember 15, 2022 | marketwatch.comBionomics Names Spyridon Papapetropoulos as President, CEODecember 15, 2022 | finance.yahoo.comBionomics appoints Spyridon “Spyros” Papapetropoulos as President and Chief Executive OfficerNovember 21, 2022 | nz.finance.yahoo.comBionomics Limited Announces Closing of US$5 Million Underwritten Offering of American Depositary Shares in the United StatesNovember 17, 2022 | marketwatch.comBionomics Shares Drop 18% After ADS Offering PricesSee More Headlines Receive BNOEF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Bionomics and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today6/14/2024Fiscal Year End6/30/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Noncommercial research organizations Sub-IndustryN/A Current SymbolOTCMKTS:BNOEF CUSIPN/A CIK1191070 Webwww.bionomics.com.au Phone(188) 150-7400FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares1,309,557,000Free FloatN/AMarket Cap$4.45 million OptionableNot Optionable Beta1.86 Elon Musk's Next MoveWondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.Get This Free Report Key ExecutivesMr. Adrian Hinton BEC (Age 70)F.C.A., Financial Controller Comp: $205.67kDr. Spyridon Papapetropoulos M.D. (Age 50)Ph.D., CEO, Pres & Director Mr. Timothy M. Cunningham CPA (Age 60)CPA, M.B.A., Chief Financial Officer Prof. Paul Rolan D.C.P.S.A.F.F.P.M., F.R.A.C.P., M.B.B.S., M.D., Consultant Chief Medical Officer of Clinical NeuroscienceDr. Julie Kerner Ph.D.Sr. VP of Bus. OperationsDr. Atul R. Mahableshwarkar DFAPAM.D., Acting Chief Medical OfficerMs. Suzanne Irwin B.Com.FCIS, Company Sec.More ExecutivesKey CompetitorsAgape ATPNASDAQ:ATPCQT ImagingNASDAQ:QTIKindly MDNASDAQ:KDLYVBI VaccinesNASDAQ:VBIVNutralife BiosciencesOTCMKTS:NTFUView All Competitors BNOEF Stock Analysis - Frequently Asked Questions How have BNOEF shares performed in 2024? Bionomics' stock was trading at $0.0034 at the beginning of the year. Since then, BNOEF stock has increased by 0.0% and is now trading at $0.0034. View the best growth stocks for 2024 here. How do I buy shares of Bionomics? Shares of BNOEF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:BNOEF) was last updated on 6/14/2024 by MarketBeat.com Staff From Our PartnersJeff Bezos & 48 Members of Congress Are Buying ONE Sector…Why are Warren Buffett, Jeff Bezos, Michael Bloomberg, “The Walmart Family”, Bill Gates, and 48 members of Con...InvestorPlace | SponsoredBiden’s Tax Plan Could Destroy Your Retirement Savings!Leading economists are issuing stark warnings: The anticipated capital gains tax increase under President B...GoldenCrest Metals | SponsoredLike Investing in Big Tech in the Early 2000s?More than a decade after the first Bitcoin was mined, people are finally realizing something very important......Manward Press | SponsoredThe Single Biggest Breakthrough of the Decade Billionaires, Jeff Bezos, Bill Gates, Warren Buffett, and Sir Richard Branson are rallying behind this technol...Porter & Company | SponsoredAn utter travestyThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredGold Prices Surge and This $0.32 Stock Is Reaping The RewardsGold prices are on the rise. This surge in gold prices is great news for gold mining stocks. Especially ...Market JAR | SponsoredEstee Lauder, MAC, and other beauty brands are raving about this emerging NYSE AI companyA Little-known NYSE Company is Empowering the Beauty Industry with Innovative AI and AR Tools.Financial Markets Daily | SponsoredMoonshot Coins for the Current Crypto RunAre you monitoring 13,217 cryptocurrencies everyday? If not, you could miss the ONE that can make you wealt...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bionomics Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Bionomics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.